naltrexone and s,n,n'-tripropylthiocarbamate

naltrexone has been researched along with s,n,n'-tripropylthiocarbamate in 123 studies

Research

Studies (123)

TimeframeStudies, this research(%)All Research%
pre-19906 (4.88)18.7374
1990's17 (13.82)18.2507
2000's29 (23.58)29.6817
2010's58 (47.15)24.3611
2020's13 (10.57)2.80

Authors

AuthorsStudies
Kirkham, TC1
Di Chiara, G; Imperato, A1
Van Ree, JM1
Corrigall, WA; D'Onofrio, RM; Lei, H; Linseman, MA1
Carr, KD; Uysal, S1
Cooper, SJ1
Carr, KD2
Heidbreder, C; Shippenberg, TS1
Carr, KD; Papadouka, V; Wolinsky, TD1
Funada, M; Misawa, M; Nagase, H; Narita, M; Suzuki, T1
Carr, KD; Papadouka, V1
Babovic-Vuksanovic, D; de Vries, TJ; Elmer, G; Shippenberg, TS1
Heidbreder, C; LeFevour, A; Shippenberg, TS1
Amendola, CA; Fishkin, MD; Hubbell, CL; Reid, LD; Tsai, J1
Endoh, T; Misawa, M; Mori, T; Nagase, H; Suzuki, T; Tsuji, M1
Boedeker, KL; Cramer, CM; Gardell, LR; Harris, JR; Hubbell, CL; Reid, LD1
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD1
Anton, RF1
Brodkin, ES; Carlezon, WA; Duman, RS; Hiroi, N; Lane-Ladd, SB; Nestler, EJ; Neve, RL; Olson, VG; Thome, J1
Kishimoto, Y; Misawa, M; Nagase, H; Suzuki, T; Takeda, F1
Cuison, ER; Groseclose, CH; Kelley, BM; Middaugh, LD2
Williams, KL; Woods, JH1
Bandy, AL; Lee, AM; Middaugh, LD1
Matsumiya, T; Nagase, H; Narita, M; Suzuki, T; Takeda, H; Tsuji, M1
Ball, SA; Carroll, KM; Eagan, DA; Frankforter, TL; Nich, C; O'Connor, PG; Rounsaville, BJ; Shi, J; Triffleman, EG1
Gray, RW; Yeomans, MR1
Chavkin, C; Marton-Popovici, M; McLaughlin, JP1
Carlezon, WA; Marcus, JF; Portoghese, PS; Todtenkopf, MS1
de la Torre, R; Kieffer, BL; Maldonado, R; Mendizabal, V; Ortuño, J; Robledo, P1
Ise, Y; Kishimoto, Y; Misawa, K; Narita, M; Suzuki, T; Yajima, Y1
Anggadiredja, K; Hiranita, T; Sakimura, K; Yamamoto, T1
Burns, LH; Olmstead, MC1
Burns, LH; Leri, F1
Miller, MC1
Riters, LV; Schroeder, MB1
Jasmin, L; Narasaiah, M; Tien, D1
Boettiger, CA; D'Esposito, M; Fields, HL; Mitchell, JM; Tavares, VC1
Braida, D; Gori, E; Guerini-Rocco, C; Limonta, V; Pegorini, S; Sala, M; Zani, A1
Aicardi, G; Burattini, C; Burbassi, S; Cervo, L1
Krishnan-Sarin, S; Krystal, JH; O'Malley, SS; Pittman, B; Shi, J1
Billington, CJ; Chimukangara, M; Grace, MK; Levine, AS; Naleid, AM1
Holtzman, SG; Michaels, CC1
Blendy, J; Jepson, C; Lerman, C; Patterson, F; Perkins, K; Ray, R; Rukstalis, M; Strasser, AA; Wileyto, P1
Hutchison, KE; Ray, LA1
Braida, D; Capurro, V; Fadda, P; Fratta, W; Gori, E; Limonta, V; Mascia, P; Parolaro, D; Rubino, T; Sala, M; Zani, A1
Stitzer, ML; Vandrey, R1
Chefer, VI; Shippenberg, TS1
Franck, J; Häggkvist, J; Lindholm, S1
Kato, H1
Dean, RL; Deaver, DR; Kriksciukaite, K; O'Neill, KS; Ostrovsky-Day, I; Todtenkopf, MS; Turncliff, RZ1
Gieryk, A; Kubik, J; Przewlocki, R; Solecki, W; Ziolkowska, B1
Berrendero, F; Maldonado, R; Martín-García, E; Robledo, P; Trigo, JM1
Carey, AN; Gomes, SM; McLaughlin, JP; Sperling, RE; Sypek, EI1
Chavkin, C; Li, S; Schindler, AG1
Brown, ML; Kellar, KJ; Levin, ED; Li, TK; Lumeng, L; McDowell, BE; Paige, MA; Petro, A; Rezvani, AH; Rose, JE; Slade, S; Wells, C; Xiao, Y1
Berthoud, HR; Phifer, CB; Pistell, PJ; Shin, AC1
Chung, NN; Gibula-Bruzda, E; Izdebski, J; Kotlinska, JH; Kunce, D; Pachuta, A; Schiller, PW; Witkowska, E1
Balleine, BW; Cely, IC; Maidment, NT; Wassum, KM1
Beaver, J; Bullmore, ET; Bush, MA; Gunn, RN; Hill, S; Howard, J; Long, C; Makwana, A; Matthews, PM; Miller, SR; Nathan, PJ; Newbould, RD; Passchier, J; Rabiner, EA; Reiley, R; Searle, G1
Carlezon, WA; Chartoff, EH; Cohen, BM; Damez-Werno, D; Potter, DN1
Fish, EW; Heilig, M; Krouse, MC; Malanga, CJ; Robinson, JE; Thorsell, A1
Busch, EL; Elman, I; Langleben, DD; O'Brien, CP1
Dickson, SL; Hansson, C; Shirazi, RH; Skibicka, KP1
Braley, G; Carbuto, M; D'Souza, DC; Elander, J; Perry, E; Pittman, B; Radhakrishnan, R; Ranganathan, M; Sewell, RA1
Balleine, BW; Laurent, V; Leung, B; Maidment, N1
Friedman, TC; Hamid, A; Kieffer, B; Lutfy, K; Marquez, P; Nguyen, AT1
Carlsson, A; Feltmann, K; Franck, J; Fredriksson, I; Holst, S; Schilström, B; Steensland, P1
Chavkin, C; Chavkin, NW; Gustin, RM; Hagan, CE; Lemos, JC; Messinger, DI; Neumaier, JF; Schattauer, SS; Schindler, AG; Shankar, H; Smith, JS1
Bailey, CP; Cordery, SF; Delgado-Charro, MB; Guy, RH; Husbands, SM; Ridzwan, IE; Taverner, A1
Arduino, C; Benedetti, F; Blanchard, C; Thoen, W; Vighetti, S1
Ise, Y; Katayama, S; Mori, T; Nagase, H; Suzuki, T1
Chelnokova, O; Eikemo, M; Laeng, B; Leknes, S; Løseth, G; Maurud, H; Riegels, J; Willoch, F1
Brouwer, S; Cowen, PJ; Harmer, CJ; McCabe, C; McCutcheon, R; Murray, E1
Augier, E; Dulman, RS; Flanigan, M; Heilig, M; Kejun, C; Pincus, A; Rice, KC; Schank, JR; Tapocik, JD1
Gao, MJ; Kao, JH; Law, PY; Loh, HH; Tao, PL; Yang, PP1
Bullmore, ET; Felici, A; Henderson, G; Kelly, E; Maltby, K; Mundell, SJ; Nathan, PJ; Roth, AL; Sava, A1
Ise, Y; Itoh, T; Komiya, S; Masukawa, D; Mizuo, K; Mori, T; Saeki, T; Shibasaki, M; Suzuki, T; Yoshizawa, K1
Bialy, M; Boguszewski, PM; Nikolaev, E; Nikolaev-Diak, A; Socha, A; Strefnel, M1
Bilbao, A; Heilig, M; Malanga, CJ; Robinson, JE; Sommer, WH; Spanagel, R; Thorsell, A1
Berrettini, W2
Acree, M; Adler, N; Bacchetti, P; Brown, RR; Dallman, M; Daubenmier, J; Epel, ES; Hecht, FM; Laraia, B; Lustig, RH; Mason, AE; Moran, PJ1
Bachtell, R; Hutchinson, MR; Maier, SF; Rice, KC; Wang, X; Watkins, LR1
Willyard, C1
Adler, N; Dallman, M; Daubenmier, J; Epel, ES; Gearhardt, AN; Hecht, FM; Kiernan, M; Laraia, B; Lustig, RH; Mason, AE; Puterman, E1
Abbott, S; Boyapati, V; Deakin, JF; Elliott, R; Erritzoe, D; Ersche, KD; Faluyi, Y; Faravelli, L; Fernandez-Egea, E; Flechais, RS; Kalk, NJ; Kuchibatla, SS; Lingford-Hughes, AR; McGonigle, J; Metastasio, A; Mick, I; Murphy, A; Nestor, L; Nutt, DJ; Orban, C; Passetti, F; Paterson, LM; Rabiner, EA; Reed, LJ; Robbins, TW; Smith, DG; Suckling, J; Tait, R; Taylor, EM; Waldman, AD1
Eans, SO; Ganno, ML; Hunkele, A; Le Rouzic, V; Majumdar, S; Marrone, GF; McLaughlin, JP; Pasternak, GW; Subrath, JJ; Váradi, A1
de Carvalho, CR; Takahashi, RN1
Beck-Schimmer, B; Kajdi, ME; Müller, D; Quednow, BB; Tobler, PN; Weber, SC1
Mann, K; Roos, CR; Witkiewitz, K1
Chelnokova, O; Eikemo, M; Laeng, B; Leknes, S; Løseth, G; Willoch, F1
Bullmore, ET; Deakin, B; Elliott, R; Ersche, KD; Flechais, R; Lingford-Hughes, A; McGonigle, J; Murphy, A; Nestor, LJ; Nutt, DJ; Orban, C; Paterson, LM; Rabiner, I; Reed, L; Robbins, TW; Sahakian, B; Smith, D; Suckling, J; Tait, R; Taylor, E1
Factor, JA; Panlilio, LV; Schindler, CW; Secci, ME1
Bolstridge, M; Boyce, M; Breuning Sluth, L; Flechais, RSA; Lingford-Hughes, A; McGonigle, J; Meulien, D; Mick, I; Newbould, RD; Nutt, D; Quelch, DR; Rabiner, E; Ramos, AC; Steiniger-Brach, B; van den Berg, F; von der Goltz, C; Wall, MB; Østergaard Nilausen, D1
Biele, G; Eikemo, M; Leknes, S; Thomsen, L; Willoch, F1
Gajbhiye, SV; Petare, A; Potey, AV; Salve, B; Tripathi, RK1
Anton, RF; Book, SW; Latham, PK; Myrick, H; Randall, PK; Schacht, JP; Voronin, KE1
Henderson-Redmond, AN; Lowe, TE; Morgan, DJ; Tian, XB1
Buisman-Pijlman, FTA; Hutchinson, MR; Jacobsen, JHW; Mustafa, S; Rice, KC1
Bradberry, CW; Panlilio, LV; Schindler, CW; Secci, ME1
George, O; Kallupi, M; Martin-Fardon, R; Matzeu, A; Schweitzer, P1
Bouril, A; Elman, I; Fairchild, VP; Gur, RC; Langleben, DD; Lowen, SB; Shi, Z; Wang, AL1
Heinz, A; Hoffmann, S; Leménager, T; Mann, K; Nakovics, H; Roos, CR; Witkiewitz, K1
Daniels, S; Flynn, A; Horman, T; Hudson, R; Leri, F; Levy, A; Zhou, Y1
Boettiger, CA; Da Cunha, C; Esaki, JY; Fiorenza, AM; Gomez-A, A; Robinson, DL; Shnitko, TA; Sullivan, KM; Vemuru, SR1
Jastrzebska, K; Przewlocki, R; Rodriguez Parkitna, J; Sikora, M; Skupio, U1
Eikemo, M; Leknes, S; Løseth, GE1
Andreescu, C; Hazlett, LI; Inagaki, TK1
Kranzler, HR; Mann, K; Roos, CR; Witkiewitz, K1
Brunton, C; Carroll, RM; Ewan, EE; Grace, MK; Hahn, TW; Head, MA; Jewett, DC; Klockars, A; Kwilasz, AJ; Levine, AS; Olszewski, PK; Smith, TR; Tham, RL; Wiebelhaus, JM1
MacDonald, G; Tchalova, K1
Chalhoub, RM; Kalivas, PW1
Eisenegger, C; Götzendorfer, SJ; Graf, I; Korb, S; Massaccesi, C; Sezen, P; Silani, G; Willeit, M1
Bäckström, P; Kiianmaa, K; Oinio, V; Piepponen, P; Raasmaja, A; Sundström, M; Uhari-Väänänen, J1
Bold, KW; Corbin, WR; DeMartini, KS; Fucito, LM; Kranzler, HR; Leeman, RF; Mann, K; O'Malley, SS; Roos, CR; Witkiewitz, K1
Kahnt, T; Quednow, BB; Soutschek, A; Tobler, PN; Weber, SC1
Kranzler, HR; Mann, K; Nakovics, H; Roos, CR; Votaw, VR; Witkiewitz, K1
Castillo, F; Comer, SD; Jones, JD; Kranzler, HR; Manubay, J; Martinez, S; Mogali, S; Mumtaz, M; Perez, F; Pramanik, S; Vadhan, NP1
Bower, M; de Wit, H; Hoots, JK; Nunez, C; Schepers, ST; Wardle, MC1
Antonijoan, RM; Cardona, G; Ferreri, L; Mas-Herrero, E; Pla-Juncà, F; Riba, J; Rodriguez-Fornells, A; Valle, M; Zatorre, RJ1
Byrd, ND; Gowin, JL; Kirk-Provencher, KT; Penner, AE; Ramchandani, VA; Rosenblatt, SL; Sloan, ME; Stangl, BL; Swan, JE1

Reviews

10 review(s) available for naltrexone and s,n,n'-tripropylthiocarbamate

ArticleYear
Minireview. Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behavior.
    Life sciences, 1983, Mar-07, Volume: 32, Issue:10

    Topics: Animals; Benzodiazepines; Corpus Striatum; Drinking Behavior; Enkephalins; Feeding Behavior; Food Deprivation; Humans; Hyperphagia; Motor Activity; Naloxone; Naltrexone; Narcotic Antagonists; Reward; Thirst

1983
The physiology of opiate hedonic effects and the role of opioids in motivated behavior.
    Advances in alcohol & substance abuse, 1984,Spring, Volume: 3, Issue:3

    Topics: Animals; Conditioning, Operant; Electric Stimulation; Electroshock; Emotions; Endorphins; Feeding Behavior; Humans; Hypothalamus; Medial Forebrain Bundle; Morphine; Motivation; Naloxone; Naltrexone; Narcotics; Rats; Reward; Self Stimulation; Substance-Related Disorders

1984
Neurobehavioural basis for the pharmacotherapy of alcoholism: current and future directions.
    Alcohol and alcoholism (Oxford, Oxfordshire). Supplement, 1996, Volume: 31, Issue:1

    Topics: Alcoholism; Bromocriptine; Dopamine Agonists; Female; Fluoxetine; Humans; Male; Models, Psychological; Naltrexone; Narcotic Antagonists; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress Disorders, Post-Traumatic

1996
Opioid peptides and the control of human ingestive behaviour.
    Neuroscience and biobehavioral reviews, 2002, Volume: 26, Issue:6

    Topics: Alcoholism; Appetite Regulation; Drinking Behavior; Feeding Behavior; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Substance-Related Disorders; Time Factors; Water Intoxication

2002
Contingency management: utility in the treatment of drug abuse disorders.
    Clinical pharmacology and therapeutics, 2008, Volume: 83, Issue:4

    Topics: Behavior Therapy; Buprenorphine; Cocaine-Related Disorders; Humans; Motivation; Naltrexone; Narcotic Antagonists; Patient Compliance; Receptors, Opioid, mu; Reinforcement, Psychology; Reward; Substance Abuse Detection; Substance Abuse Treatment Centers; Substance-Related Disorders; Treatment Outcome

2008
[Pharmacological effects of a mu-opioid receptor antagonist naltrexone on alcohol dependence].
    Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence, 2008, Volume: 43, Issue:5

    Topics: Alcoholism; Animals; beta-Endorphin; Dopamine; GABA Antagonists; Humans; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reinforcement, Psychology; Reward

2008
Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.
    Neuroscience and biobehavioral reviews, 2010, Volume: 35, Issue:2

    Topics: Animals; Behavior, Addictive; Humans; Motivation; Naltrexone; Neurotransmitter Agents; Nicotine; Opioid Peptides; Receptors, Nicotinic; Reinforcement, Psychology; Reward; Smoking Cessation; Tobacco Use Disorder

2010
Targeting the Toll of Drug Abuse: The Translational Potential of Toll-Like Receptor 4.
    CNS & neurological disorders drug targets, 2015, Volume: 14, Issue:6

    Topics: Animals; Central Nervous System; Humans; Naltrexone; Narcotic Antagonists; Neuroglia; Neurons; Reward; Substance-Related Disorders; Toll-Like Receptor 4; Xenobiotics

2015
Opioid neuroscience for addiction medicine: From animal models to FDA approval for alcohol addiction.
    Progress in brain research, 2016, Volume: 223

    Topics: Alcoholism; Analgesics, Opioid; Animals; Genotype; Humans; Models, Animal; Naltrexone; Reward

2016
Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date.
    Drugs, 2020, Volume: 80, Issue:15

    Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Brain; Buprenorphine; Disease Models, Animal; Endocannabinoids; Glutamic Acid; Humans; Methadone; Naltrexone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Orexins; Reward; Secondary Prevention; Signal Transduction; Treatment Outcome

2020

Trials

28 trial(s) available for naltrexone and s,n,n'-tripropylthiocarbamate

ArticleYear
Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence: efficacy of contingency management and significant other involvement.
    Archives of general psychiatry, 2001, Volume: 58, Issue:8

    Topics: Adult; Behavior Therapy; Combined Modality Therapy; Family Therapy; Female; Humans; Interpersonal Relations; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Patient Dropouts; Reward; Substance Abuse Detection; Treatment Outcome; Treatment Refusal

2001
Endogenous opioid blockade and impulsive responding in alcoholics and healthy controls.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2007, Volume: 32, Issue:2

    Topics: Adult; Alcoholism; Bias; Brain; Causality; Central Nervous System Depressants; Choice Behavior; Decision Making; Double-Blind Method; Ethanol; Female; Humans; Impulsive Behavior; Male; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Opioid Peptides; Personality; Psychomotor Performance; Reward; Treatment Outcome

2007
Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study.
    Archives of general psychiatry, 2007, Volume: 64, Issue:9

    Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Breath Tests; Double-Blind Method; Emotions; Ethanol; Female; Genetic Variation; Genotype; Humans; Male; Naltrexone; Narcotic Antagonists; Pharmacogenetics; Placebos; Polymorphism, Single Nucleotide; Prospective Studies; Receptors, Opioid, mu; Reward

2007
Pharmacological differentiation of opioid receptor antagonists by molecular and functional imaging of target occupancy and food reward-related brain activation in humans.
    Molecular psychiatry, 2011, Volume: 16, Issue:8

    Topics: Adult; Amygdala; Brain; Brain Mapping; Corpus Striatum; Dose-Response Relationship, Drug; Fentanyl; Food; Humans; Indans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Radioligand Assay; Radionuclide Imaging; Reward; Triazoles

2011
Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.
    Psychopharmacology, 2012, Volume: 220, Issue:3

    Topics: Adult; Analysis of Variance; Cues; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pilot Projects; Reward; Substance Abuse, Intravenous; Sucrose; Taste Perception

2012
Naltrexone does not attenuate the effects of intravenous Δ9-tetrahydrocannabinol in healthy humans.
    The international journal of neuropsychopharmacology, 2012, Volume: 15, Issue:9

    Topics: Adolescent; Adult; Attention; Behavior; Cognition; Cognition Disorders; Double-Blind Method; Dronabinol; Drug Interactions; Euphoria; Female; Hallucinogens; Humans; Inhibition, Psychological; Injections, Intravenous; Male; Marijuana Abuse; Memory; Mental Recall; Middle Aged; Naltrexone; Narcotic Antagonists; Orientation; Perception; Psychoses, Substance-Induced; Recognition, Psychology; Reward; Young Adult

2012
Pain as a reward: changing the meaning of pain from negative to positive co-activates opioid and cannabinoid systems.
    Pain, 2013, Volume: 154, Issue:3

    Topics: Adult; Arm; Attitude to Health; Cannabinoid Receptor Antagonists; Culture; Double-Blind Method; Female; Humans; Ischemia; Male; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pain; Persuasive Communication; Physical Endurance; Piperidines; Pyrazoles; Receptors, Cannabinoid; Reward; Rimonabant; Suggestion; Time Factors; Young Adult

2013
Rewards of beauty: the opioid system mediates social motivation in humans.
    Molecular psychiatry, 2014, Volume: 19, Issue:7

    Topics: Analgesics, Opioid; Beauty; Cross-Over Studies; Double-Blind Method; Face; Humans; Male; Morphine; Motivation; Naltrexone; Narcotic Antagonists; Photic Stimulation; Receptors, Opioid, mu; Reward

2014
Opposing neural effects of naltrexone on food reward and aversion: implications for the treatment of obesity.
    Psychopharmacology, 2014, Volume: 231, Issue:22

    Topics: Adult; Affect; Brain Mapping; Cerebrum; Double-Blind Method; Female; Food; Humans; Magnetic Resonance Imaging; Naltrexone; Narcotic Antagonists; Obesity; Reward; Taste; Young Adult

2014
Acute responses to opioidergic blockade as a biomarker of hedonic eating among obese women enrolled in a mindfulness-based weight loss intervention trial.
    Appetite, 2015, Volume: 91

    Topics: Adult; Behavior, Addictive; Binge-Eating Disorder; Body Mass Index; Body Weight; Bulimia; Eating; Emotions; Female; Humans; Hydrocortisone; Middle Aged; Mindfulness; Motivation; Naltrexone; Narcotic Antagonists; Nausea; Obesity; Opioid Peptides; Receptors, Opioid; Reward; Stress, Psychological; Weight Reduction Programs

2015
Putting the brakes on the "drive to eat": Pilot effects of naltrexone and reward-based eating on food cravings among obese women.
    Eating behaviors, 2015, Volume: 19

    Topics: Adult; Craving; Eating; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Obesity; Pilot Projects; Reward; Treatment Outcome; Young Adult

2015
The Imperial College Cambridge Manchester (ICCAM) platform study: An experimental medicine platform for evaluating new drugs for relapse prevention in addiction. Part A: Study description.
    Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:9

    Topics: Adult; Behavior, Addictive; Biomedical Research; Brain; Cocaine; Cross-Over Studies; Drug Discovery; Ethanol; Female; Humans; Impulsive Behavior; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Neurokinin-1 Receptor Antagonists; Pharmaceutical Preparations; Receptors, Dopamine D3; Receptors, Neurokinin-1; Reward; Secondary Prevention; Substance-Related Disorders

2015
Dopamine D2/3- and μ-opioid receptor antagonists reduce cue-induced responding and reward impulsivity in humans.
    Translational psychiatry, 2016, 07-05, Volume: 6, Issue:7

    Topics: Amisulpride; Cues; Delay Discounting; Dopamine Antagonists; Double-Blind Method; Female; Healthy Volunteers; Humans; Impulsive Behavior; Male; Naltrexone; Narcotic Antagonists; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Opioid, mu; Reward; Sulpiride; Young Adult

2016
Reward and relief dimensions of temptation to drink: construct validity and role in predicting differential benefit from acamprosate and naltrexone.
    Addiction biology, 2017, Volume: 22, Issue:6

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Reproducibility of Results; Reward; Taurine; Treatment Outcome

2017
Acute naltrexone does not remediate fronto-striatal disturbances in alcoholic and alcoholic polysubstance-dependent populations during a monetary incentive delay task.
    Addiction biology, 2017, Volume: 22, Issue:6

    Topics: Adult; Alcoholism; Corpus Striatum; Delay Discounting; Double-Blind Method; Female; Humans; Male; Middle Aged; Motivation; Naltrexone; Narcotic Antagonists; Reward; Substance-Related Disorders; United Kingdom

2017
Nalmefene Reduces Reward Anticipation in Alcohol Dependence: An Experimental Functional Magnetic Resonance Imaging Study.
    Biological psychiatry, 2017, 06-01, Volume: 81, Issue:11

    Topics: Administration, Intravenous; Adult; Alcoholism; Anticipation, Psychological; Corpus Striatum; Double-Blind Method; Drug Synergism; Ethanol; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Reward

2017
Opioid Modulation of Value-Based Decision-Making in Healthy Humans.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:9

    Topics: Adult; Analgesics, Opioid; Computer Simulation; Cross-Over Studies; Decision Making; Double-Blind Method; Humans; Models, Neurological; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Reaction Time; Receptors, Opioid, mu; Reward; Young Adult

2017
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:13

    Topics: Alcoholism; Brain; Brain Mapping; Cues; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Pharmacogenomic Variants; Prognosis; Receptors, Opioid, mu; Reward; Severity of Illness Index; Single-Blind Method; Smoking; Visual Perception

2017
Precision Medicine in Alcohol Dependence: A Controlled Trial Testing Pharmacotherapy Response Among Reward and Relief Drinking Phenotypes.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:4

    Topics: Acamprosate; Adult; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Phenotype; Precision Medicine; Reward; Treatment Outcome

2018
Effects of opioid receptor stimulation and blockade on touch pleasantness: a double-blind randomised trial.
    Social cognitive and affective neuroscience, 2019, 05-17, Volume: 14, Issue:4

    Topics: Adult; Analgesics, Opioid; Cross-Over Studies; Double-Blind Method; Emotions; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Reward; Touch; Touch Perception; Young Adult

2019
Opioids and social bonding: Effect of naltrexone on feelings of social connection and ventral striatum activity to close others.
    Journal of experimental psychology. General, 2020, Volume: 149, Issue:4

    Topics: Adolescent; Adult; Emotions; Female; Humans; Magnetic Resonance Imaging; Male; Naltrexone; Narcotic Antagonists; Reward; Social Behavior; Ventral Striatum; Young Adult

2020
Advancing Precision Medicine for Alcohol Use Disorder: Replication and Extension of Reward Drinking as a Predictor of Naltrexone Response.
    Alcoholism, clinical and experimental research, 2019, Volume: 43, Issue:11

    Topics: Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Middle Aged; Naltrexone; Precision Medicine; Reward; Treatment Outcome

2019
Opioid receptor blockade inhibits self-disclosure during a closeness-building social interaction.
    Psychoneuroendocrinology, 2020, Volume: 113

    Topics: Adolescent; Adult; Double-Blind Method; Emotions; Female; Humans; Interpersonal Relations; Male; Motivation; Naltrexone; Narcotic Antagonists; Personality; Receptors, Opioid; Reward; Self Disclosure; Social Interaction; Young Adult

2020
Reward drinking and naltrexone treatment response among young adult heavy drinkers.
    Addiction (Abingdon, England), 2021, Volume: 116, Issue:9

    Topics: Adolescent; Adult; Alcohol Drinking; Alcoholism; Blood Alcohol Content; Female; Humans; Male; Naltrexone; Reward; Young Adult

2021
Opioid antagonism modulates wanting-related frontostriatal connectivity.
    eLife, 2021, 11-11, Volume: 10

    Topics: Adult; Amisulpride; Corpus Striatum; Dopamine Antagonists; Dorsolateral Prefrontal Cortex; Double-Blind Method; Female; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Motivation; Naltrexone; Narcotic Antagonists; Reward

2021
The effects of acute oral naltrexone pretreatment on the abuse potential of intranasal methamphetamine, and the relationship between reward/punishment sensitivity and methamphetamine's effects.
    Behavioural pharmacology, 2022, 06-01, Volume: 33, Issue:4

    Topics: Adult; Central Nervous System Stimulants; Double-Blind Method; Female; Humans; Male; Methamphetamine; Naltrexone; Punishment; Reward

2022
The role of opioid transmission in music-induced pleasure.
    Annals of the New York Academy of Sciences, 2023, Volume: 1520, Issue:1

    Topics: Analgesics, Opioid; Music; Naltrexone; Oxycodone; Pleasure; Reward

2023
Opioid receptor antagonism and neural response to monetary rewards: Pilot studies in light and heavy alcohol users.
    Journal of psychopharmacology (Oxford, England), 2023, Volume: 37, Issue:9

    Topics: Alcoholism; Analgesics, Opioid; Humans; Magnetic Resonance Imaging; Naltrexone; Narcotic Antagonists; Pilot Projects; Receptors, Opioid; Reward

2023

Other Studies

85 other study(ies) available for naltrexone and s,n,n'-tripropylthiocarbamate

ArticleYear
Opioids and feeding reward.
    Appetite, 1991, Volume: 17, Issue:1

    Topics: Animals; Appetite Regulation; Endorphins; Feeding Behavior; Naloxone; Naltrexone; Rats; Reward

1991
Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 244, Issue:3

    Topics: Animals; Benzomorphans; Caudate Nucleus; Dopamine; Male; Methadone; Morphine; Motor Activity; Naloxone; Naltrexone; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Septal Nuclei

1988
Role of pituitary and related neuropeptides in alcoholism and pharmacodependence.
    Progress in neuro-psychopharmacology & biological psychiatry, 1986, Volume: 10, Issue:2

    Topics: Adrenocorticotropic Hormone; Alcoholism; Animals; Arginine Vasopressin; beta-Endorphin; Brain; Endorphins; Haplorhini; Heroin Dependence; Humans; Melanocyte-Stimulating Hormones; Naltrexone; Neurotransmitter Agents; Peptides; Pituitary Gland; Rats; Reinforcement, Psychology; Reward; Substance-Related Disorders

1986
An analysis of the paradoxical effect of morphine on runway speed and food consumption.
    Psychopharmacology, 1986, Volume: 89, Issue:3

    Topics: Animals; Avoidance Learning; Feeding Behavior; Food Deprivation; Male; Morphine; Motivation; Naltrexone; Nervous System; Quaternary Ammonium Compounds; Rats; Rats, Inbred Strains; Reward; Taste; Tegmentum Mesencephali

1986
Evidence of a supraspinal opioid analgesic mechanism engaged by lateral hypothalamic electrical stimulation.
    Brain research, 1985, May-27, Volume: 335, Issue:1

    Topics: Animals; Brain Mapping; Electric Stimulation; Endorphins; Hypothalamic Area, Lateral; Male; Naltrexone; Pain; Rats; Rats, Inbred Strains; Reward; Sensory Thresholds

1985
The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine.
    European journal of pharmacology, 1995, Jun-23, Volume: 280, Issue:1

    Topics: Animals; Association Learning; Cocaine; Conditioning, Operant; Drug Interactions; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Sensitivity and Specificity

1995
Norbinaltorphimine blocks the feeding but not the reinforcing effect of lateral hypothalamic electrical stimulation.
    Psychopharmacology, 1993, Volume: 111, Issue:3

    Topics: Animals; Electric Stimulation; Feeding Behavior; Hypothalamic Area, Lateral; Injections, Intraventricular; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation

1993
Streptozotocin-induced diabetes produces a naltrexone-reversible lowering of self-stimulation threshold.
    Brain research, 1994, Nov-21, Volume: 664, Issue:1-2

    Topics: Animals; Diabetes Mellitus, Experimental; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reward; Self Stimulation; Streptozocin

1994
Blockade of morphine reward through the activation of kappa-opioid receptors in mice.
    Neuropharmacology, 1993, Volume: 32, Issue:12

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; 3,4-Dihydroxyphenylacetic Acid; Analgesics; Animals; Apomorphine; Conditioning, Operant; Dopamine; Dynorphins; Homovanillic Acid; Injections, Subcutaneous; Limbic System; Male; Mice; Mice, Inbred Strains; Morphine; Motivation; Naltrexone; Peptide Fragments; Prosencephalon; Pyrrolidines; Receptors, Opioid, kappa; Reward

1993
The role of multiple opioid receptors in the potentiation of reward by food restriction.
    Brain research, 1994, Mar-14, Volume: 639, Issue:2

    Topics: Animals; Behavior, Animal; Brain; Conditioning, Operant; Dose-Response Relationship, Drug; Food Deprivation; Injections, Intraventricular; Male; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Self Stimulation

1994
Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine.
    Psychopharmacology, 1995, Volume: 120, Issue:4

    Topics: Animals; Benzazepines; Cocaine; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Self Administration; Time Factors

1995
kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 276, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Benzeneacetamides; Cocaine; Conditioning, Psychological; Dopamine; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward

1996
Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation.
    Pharmacology, biochemistry, and behavior, 1996, Volume: 53, Issue:2

    Topics: Animals; Brain; Electric Stimulation; Male; Medial Forebrain Bundle; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reward; Self Stimulation; Serotonin Agents

1996
Effect of the highly selective and nonpeptide delta opioid receptor agonist TAN-67 on the morphine-induced place preference in mice.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:1

    Topics: Analgesics; Animals; Benzylidene Compounds; Dopamine; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Limbic System; Male; Mice; Morphine; Naltrexone; Quinolines; Receptors, Opioid, delta; Reward

1996
Isradipine combined with naltrexone persistently reduces the reward-relevant effects of cocaine and alcohol.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 60, Issue:2

    Topics: Animals; Body Weight; Calcium Channel Blockers; Central Nervous System Depressants; Cocaine; Conditioning, Operant; Drinking; Drug Interactions; Ethanol; Isradipine; Male; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward

1998
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone.
    Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:2

    Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid

1998
Regulation of cocaine reward by CREB.
    Science (New York, N.Y.), 1998, Dec-18, Volume: 282, Issue:5397

    Topics: Animals; Cocaine; Conditioning, Psychological; Cyclic AMP Response Element-Binding Protein; Dose-Response Relationship, Drug; Dynorphins; Gene Expression; Gene Expression Regulation; Gene Transfer Techniques; Genetic Vectors; Naltrexone; Narcotic Antagonists; Neurons; Nucleus Accumbens; Point Mutation; Rats; Receptors, Opioid, kappa; Reward; RNA, Messenger; Simplexvirus

1998
Role of the kappa-opioid system in the attenuation of the morphine-induced place preference under chronic pain.
    Life sciences, 1999, Volume: 64, Issue:1

    Topics: Animals; Chronic Disease; Conditioning, Psychological; Formaldehyde; Hindlimb; Inflammation; Male; Morphine; Naltrexone; Pain; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Receptors, Opioid, kappa; Reward; Time Factors

1999
Naltrexone effects on ethanol reward and discrimination in C57BL/6 mice.
    Alcoholism, clinical and experimental research, 1999, Volume: 23, Issue:3

    Topics: Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Ethanol; Food Deprivation; Generalization, Response; Habituation, Psychophysiologic; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Reinforcement Schedule; Reward

1999
Conditioned effects produced by naltrexone doses that reduce ethanol-reinforced responding in rhesus monkeys.
    Alcoholism, clinical and experimental research, 1999, Volume: 23, Issue:4

    Topics: Alcohol Drinking; Animals; Avoidance Learning; Behavior, Animal; Conditioning, Classical; Conditioning, Operant; Drinking Behavior; Ethanol; Macaca mulatta; Male; Naltrexone; Reward; Sodium Chloride; Taste

1999
Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice.
    Pharmacology, biochemistry, and behavior, 2000, Jan-01, Volume: 65, Issue:1

    Topics: Animals; Conditioning, Operant; Discrimination Learning; Dose-Response Relationship, Drug; Ethanol; Female; Male; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Reinforcement, Psychology; Reward; Serotonin Antagonists; Tropanes

2000
Ethanol reinforcement in nondeprived mice: effects of abstinence and naltrexone.
    Alcoholism, clinical and experimental research, 2000, Volume: 24, Issue:8

    Topics: Animals; Ethanol; Food Deprivation; Male; Mice; Mice, Inbred C57BL; Naltrexone; Reinforcement, Psychology; Reward; Saccharin; Self Administration; Solutions; Sucrose; Water Deprivation

2000
The novel kappa-opioid receptor agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice.
    Life sciences, 2001, Mar-02, Volume: 68, Issue:15

    Topics: Animals; Dose-Response Relationship, Drug; Male; Mice; Morphinans; Morphine; Motor Activity; Naltrexone; Narcotics; Receptors, Opioid, kappa; Reward; Spiro Compounds

2001
Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2003, Jul-02, Volume: 23, Issue:13

    Topics: Analgesia; Animals; Behavior, Animal; Cocaine; Drug Synergism; Enkephalins; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Naltrexone; Narcotic Antagonists; Pain Threshold; Protein Precursors; Reaction Time; Receptors, Opioid, kappa; Reward; Spatial Behavior; Stress, Physiological; Swimming

2003
Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats.
    Psychopharmacology, 2004, Volume: 172, Issue:4

    Topics: Animals; Behavior, Animal; Benzeneacetamides; Brain; Dose-Response Relationship, Drug; Drug Interactions; Dynorphins; Electric Stimulation; Electrodes, Implanted; Injections, Intraperitoneal; Ligands; Male; Naltrexone; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation; Time Factors

2004
The rewarding properties of MDMA are preserved in mice lacking mu-opioid receptors.
    The European journal of neuroscience, 2004, Volume: 20, Issue:3

    Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Avoidance Learning; Brain Chemistry; Chromatography, High Pressure Liquid; Dialysis; Dopamine; Homovanillic Acid; Mice; Mice, Inbred Strains; Mice, Knockout; N-Methyl-3,4-methylenedioxyamphetamine; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Receptors, Opioid, mu; Reward; Species Specificity; Time Factors

2004
Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2005, Volume: 30, Issue:1

    Topics: Animals; Brain Chemistry; Conditioning, Operant; Dopamine; Dynorphins; Edema; Foot; Formaldehyde; Inflammation; Limbic System; Male; Microdialysis; Microinjections; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward

2005
Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward.
    Brain research, 2004, Sep-24, Volume: 1021, Issue:2

    Topics: Animals; Behavior, Addictive; Central Nervous System Stimulants; Conditioning, Operant; Male; Methamphetamine; Naltrexone; Narcotic Antagonists; Rats; Reward; Self Administration

2004
Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats.
    Psychopharmacology, 2005, Volume: 181, Issue:3

    Topics: Animals; Avoidance Learning; Conditioning, Classical; Dose-Response Relationship, Drug; Female; Injections, Subcutaneous; Morphine Dependence; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Orientation; Oxycodone; Rats; Rats, Sprague-Dawley; Reward; Substance Withdrawal Syndrome

2005
Ultra-low-dose naltrexone reduces the rewarding potency of oxycodone and relapse vulnerability in rats.
    Pharmacology, biochemistry, and behavior, 2005, Volume: 82, Issue:2

    Topics: Animals; Avoidance Learning; Conditioning, Operant; Cues; Electroshock; Extinction, Psychological; Male; Motor Activity; Naltrexone; Narcotic Antagonists; Narcotics; Oxycodone; Rats; Rats, Sprague-Dawley; Recurrence; Reinforcement Schedule; Reward; Self Administration

2005
Health for life. Addiction: how to break the chain.
    Newsweek, 2005, Dec-12, Volume: 146, Issue:24

    Topics: Behavior, Addictive; Brain; Dopamine Agonists; Humans; Naltrexone; Narcotic Antagonists; Reinforcement, Psychology; Reward; Substance-Related Disorders; United States

2005
Pharmacological manipulations of dopamine and opioids have differential effects on sexually motivated song in male European starlings.
    Physiology & behavior, 2006, Jul-30, Volume: 88, Issue:4-5

    Topics: Analgesics, Opioid; Animals; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Implants; Female; Fentanyl; Male; Motivation; Naltrexone; Narcotic Antagonists; Orchiectomy; Piperazines; Receptors, Dopamine D1; Receptors, Opioid; Reward; Sexual Behavior, Animal; Starlings; Testosterone; Vocalization, Animal

2006
Noradrenaline is necessary for the hedonic properties of addictive drugs.
    Vascular pharmacology, 2006, Volume: 45, Issue:4

    Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Appetitive Behavior; Benzazepines; Biphenyl Compounds; Bupropion; Carbidopa; Cocaine; Dopamine beta-Hydroxylase; Dopamine Uptake Inhibitors; Droxidopa; Female; Genotype; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Norepinephrine; Receptors, Adrenergic, alpha-1; Receptors, Dopamine D1; Reward; Substance-Related Disorders

2006
Hallucinatory and rewarding effect of salvinorin A in zebrafish: kappa-opioid and CB1-cannabinoid receptor involvement.
    Psychopharmacology, 2007, Volume: 190, Issue:4

    Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Psychological; Diterpenes; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Hallucinogens; Models, Animal; Motor Activity; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid, kappa; Reinforcement, Psychology; Reproducibility of Results; Reward; Rimonabant; Swimming; Time Factors; Zebrafish

2007
Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats.
    The international journal of neuropsychopharmacology, 2008, Volume: 11, Issue:1

    Topics: Animals; Behavior, Animal; Cocaine-Related Disorders; Cues; Data Interpretation, Statistical; Dose-Response Relationship, Drug; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Self Administration; Sucrose

2008
Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.
    Biological psychiatry, 2007, Sep-15, Volume: 62, Issue:6

    Topics: Adult; Alcohol Drinking; Alcoholism; Behavior, Addictive; Choice Behavior; Dose-Response Relationship, Drug; Family; Female; Genetic Predisposition to Disease; Humans; Male; Naltrexone; Narcotic Antagonists; Reward; Sex Factors; Treatment Outcome

2007
Paraventricular opioids alter intake of high-fat but not high-sucrose diet depending on diet preference in a binge model of feeding.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2007, Volume: 293, Issue:1

    Topics: Analgesics, Opioid; Animals; Bulimia Nervosa; Diet; Dietary Fats; Dose-Response Relationship, Drug; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Preferences; Homeostasis; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Paraventricular Hypothalamic Nucleus; Rats; Rats, Sprague-Dawley; Reward; Sucrose

2007
Enhanced sensitivity to naltrexone-induced drinking suppression of fluid intake and sucrose consumption in maternally separated rats.
    Pharmacology, biochemistry, and behavior, 2007, Volume: 86, Issue:4

    Topics: Animals; Brain; Drinking; Female; Food Preferences; Male; Models, Animal; Naltrexone; Narcotic Antagonists; Opioid Peptides; Pregnancy; Rats; Rats, Long-Evans; Reward; Sex Characteristics; Solutions; Stress, Psychological; Substance-Related Disorders; Sucrose

2007
CREB1 haplotypes and the relative reinforcing value of nicotine.
    Molecular psychiatry, 2007, Volume: 12, Issue:7

    Topics: Association Learning; Case-Control Studies; Choice Behavior; Cyclic AMP Response Element-Binding Protein; Double-Blind Method; Haplotypes; Humans; Linkage Disequilibrium; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Polymorphism, Single Nucleotide; Receptors, Opioid, mu; Regression Analysis; Reward; Smoking; Tobacco Use Disorder

2007
Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward.
    Biological psychiatry, 2008, Feb-01, Volume: 63, Issue:3

    Topics: Analysis of Variance; Animals; Antioxidants; Behavior, Animal; Cannabinoid Receptor Modulators; Conditioning, Operant; Diterpenes; Diterpenes, Clerodane; Dopamine; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Interactions; Endocannabinoids; Male; Microdialysis; Motor Activity; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Opioid, kappa; Reward; Rimonabant; Self Administration

2008
Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009, Volume: 34, Issue:4

    Topics: Animals; Conditioning, Psychological; Drug Tolerance; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Morphine; Motor Activity; Naltrexone; Narcotic Antagonists; Receptors, Opioid, delta; Reward; Spatial Behavior

2009
The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat.
    Behavioural brain research, 2009, Jan-30, Volume: 197, Issue:1

    Topics: Amphetamine; Animals; Appetitive Behavior; Behavior, Addictive; Behavior, Animal; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Extinction, Psychological; Feeding Behavior; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Self Administration; Substance Abuse, Intravenous

2009
Route of administration affects the ability of naltrexone to reduce amphetamine-potentiated brain stimulation reward in rats.
    Addiction biology, 2009, Volume: 14, Issue:4

    Topics: Administration, Oral; Animals; Brain; Central Nervous System Stimulants; Dextroamphetamine; Drug Administration Routes; Drug Administration Schedule; Gas Chromatography-Mass Spectrometry; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward

2009
Forebrain PENK and PDYN gene expression levels in three inbred strains of mice and their relationship to genotype-dependent morphine reward sensitivity.
    Psychopharmacology, 2010, Volume: 208, Issue:2

    Topics: Animals; Behavior, Addictive; Behavior, Animal; Conditioning, Psychological; Cues; Enkephalins; Gene Expression Regulation; Genotype; In Situ Hybridization; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Morphine Dependence; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Phenotype; Protein Precursors; Receptors, Opioid, kappa; Reward; RNA, Messenger; Species Specificity

2010
Endogenous kappa-opioid mediation of stress-induced potentiation of ethanol-conditioned place preference and self-administration.
    Psychopharmacology, 2010, Volume: 210, Issue:2

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Conditioning, Psychological; Enkephalins; Ethanol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Protein Precursors; Receptors, Opioid, kappa; Reward; Self Administration; Signal Transduction; Stress, Physiological

2010
Behavioral stress may increase the rewarding valence of cocaine-associated cues through a dynorphin/kappa-opioid receptor-mediated mechanism without affecting associative learning or memory retrieval mechanisms.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:9

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analysis of Variance; Anesthetics, Local; Animals; Association Learning; Behavior, Animal; Cocaine; Conditioning, Operant; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Dynorphins; Exploratory Behavior; Male; Mental Recall; Mice; Mice, Inbred C57BL; Naltrexone; Narcotic Antagonists; Receptors, Opioid, kappa; Reward; Stress, Psychological; Swimming

2010
Effects of sazetidine-A, a selective alpha4beta2 nicotinic acetylcholine receptor desensitizing agent on alcohol and nicotine self-administration in selectively bred alcohol-preferring (P) rats.
    Psychopharmacology, 2010, Volume: 211, Issue:2

    Topics: Animals; Azetidines; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethanol; Male; Naltrexone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Pyridines; Rats; Receptors, Nicotinic; Reward; Saccharin; Self Administration

2010
Reversible suppression of food reward behavior by chronic mu-opioid receptor antagonism in the nucleus accumbens.
    Neuroscience, 2010, Oct-13, Volume: 170, Issue:2

    Topics: Animals; Appetitive Behavior; Male; Microinjections; Motivation; Naltrexone; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Reinforcement, Psychology; Reward; Sucrose

2010
Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats.
    Behavioural pharmacology, 2010, Volume: 21, Issue:7

    Topics: Animals; Behavior, Addictive; Behavioral Research; Cocaine; Conditioning, Psychological; Infusions, Intraventricular; Maze Learning; Motor Activity; Naltrexone; Narcotic Antagonists; Oligopeptides; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid, delta; Reward

2010
Micro-opioid receptor activation in the basolateral amygdala mediates the learning of increases but not decreases in the incentive value of a food reward.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2011, Feb-02, Volume: 31, Issue:5

    Topics: Amygdala; Animals; Conditioning, Operant; Drive; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, Leucine; Food; Guanidines; Male; Microinjections; Morphinans; Naltrexone; Narcotic Antagonists; Neuropsychological Tests; Rats; Rats, Long-Evans; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Somatostatin; Sucrose

2011
Repeated exposure to the κ-opioid receptor agonist salvinorin A modulates extracellular signal-regulated kinase and reward sensitivity.
    Biological psychiatry, 2011, Oct-15, Volume: 70, Issue:8

    Topics: Animals; Cocaine; Cyclic AMP Response Element-Binding Protein; Diterpenes, Clerodane; Drug Interactions; Extracellular Signal-Regulated MAP Kinases; Male; Naltrexone; Nucleus Accumbens; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reward; Self Stimulation; Signal Transduction; Time Factors

2011
Potentiation of brain stimulation reward by morphine: effects of neurokinin-1 receptor antagonism.
    Psychopharmacology, 2012, Volume: 220, Issue:1

    Topics: Analgesics, Opioid; Animals; Brain; Dose-Response Relationship, Drug; Electric Stimulation; Male; Mice; Mice, Inbred C57BL; Morphine; Naltrexone; Narcotic Antagonists; Neurokinin-1 Receptor Antagonists; Piperidines; Quinuclidines; Reinforcement, Psychology; Reward; Substance P

2012
Ghrelin interacts with neuropeptide Y Y1 and opioid receptors to increase food reward.
    Endocrinology, 2012, Volume: 153, Issue:3

    Topics: Animal Feed; Animals; Feeding Behavior; Ghrelin; Homeostasis; Infusions, Intraventricular; Male; Models, Biological; Motivation; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, Opioid, mu; Reward; Sucrose; Ventral Tegmental Area

2012
μ- and δ-opioid-related processes in the accumbens core and shell differentially mediate the influence of reward-guided and stimulus-guided decisions on choice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Feb-01, Volume: 32, Issue:5

    Topics: Animals; Choice Behavior; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Naltrexone; Nucleus Accumbens; Peptide Fragments; Random Allocation; Rats; Rats, Long-Evans; Receptors, Opioid, delta; Receptors, Opioid, mu; Reward; Somatostatin

2012
The rewarding action of acute cocaine is reduced in β-endorphin deficient but not in μ opioid receptor knockout mice.
    European journal of pharmacology, 2012, Jul-05, Volume: 686, Issue:1-3

    Topics: Animals; Behavior, Animal; beta-Endorphin; Cocaine; Conditioning, Operant; Male; Mice; Mice, Knockout; Morphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reward

2012
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbens.
    Biological psychiatry, 2012, Nov-15, Volume: 72, Issue:10

    Topics: Alcohol Drinking; Animals; Behavioral Symptoms; Cues; Disease Models, Animal; Dopamine; Drug Discovery; Ethanol; Male; Microdialysis; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Piperidines; Rats; Reward; Secondary Prevention; Substance Withdrawal Syndrome

2012
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2012, Dec-05, Volume: 32, Issue:49

    Topics: Animals; Avoidance Learning; Brain; Cocaine; Corpus Striatum; Dopamine; Dynorphins; G-Protein-Coupled Receptor Kinase 3; Male; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microinjections; Naltrexone; Narcotic Antagonists; Nicotine; Nucleus Accumbens; p38 Mitogen-Activated Protein Kinases; Raphe Nuclei; Receptors, Opioid, kappa; Reward; Serotonin; Serotonin Plasma Membrane Transport Proteins; Signal Transduction; Stress, Psychological; Substance Withdrawal Syndrome; Synaptosomes

2012
A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.
    Addiction biology, 2014, Volume: 19, Issue:4

    Topics: Animals; Behavior, Animal; Buprenorphine; Cocaine; Conditioning, Psychological; Cues; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Therapy, Combination; Male; Morphine; Naltrexone; Narcotic Antagonists; Narcotics; Rats; Rats, Sprague-Dawley; Reward

2014
Rewarding effects of ethanol combined with low doses of morphine through dopamine D1 receptors.
    Journal of Nippon Medical School = Nippon Ika Daigaku zasshi, 2013, Volume: 80, Issue:1

    Topics: Analgesics, Opioid; Animals; Benzazepines; Central Nervous System Depressants; Conditioning, Psychological; Dose-Response Relationship, Drug; Ethanol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Reward

2013
Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training.
    Psychopharmacology, 2014, Volume: 231, Issue:23

    Topics: Animals; Behavior, Animal; Conditioning, Operant; Ethanol; Male; Motivation; Naltrexone; Rats; Rats, Wistar; Reinforcement, Psychology; Reward; Saccharin; Self Administration; Sucrose; Water Deprivation

2014
Effect of naltrexone on neuropathic pain in mice locally transfected with the mutant μ-opioid receptor gene in spinal cord.
    British journal of pharmacology, 2015, Volume: 172, Issue:2

    Topics: Analgesics; Animals; Conditioning, Psychological; Genetic Vectors; HEK293 Cells; Humans; Lentivirus; Male; Mice, Inbred C57BL; Morphine; Mutation; Naltrexone; Narcotic Antagonists; Neuralgia; Receptors, Opioid, mu; Reward; Spinal Cord; Spinal Nerves; Substance Withdrawal Syndrome; Transfection

2015
The opioid receptor pharmacology of GSK1521498 compared to other ligands with differential effects on compulsive reward-related behaviours.
    Psychopharmacology, 2015, Volume: 232, Issue:1

    Topics: Analgesics, Opioid; Animals; CHO Cells; Compulsive Behavior; Cricetinae; Cricetulus; Guanosine 5'-O-(3-Thiotriphosphate); HEK293 Cells; Humans; Indans; Ligands; Male; Mice; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Protein Binding; Receptors, Opioid, mu; Reward; Treatment Outcome; Triazoles

2015
Involvement of μ- and δ-opioid receptor function in the rewarding effect of (±)-pentazocine.
    Addiction biology, 2015, Volume: 20, Issue:4

    Topics: Analgesics, Opioid; Analysis of Variance; Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Isomerism; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nucleus Accumbens; Pain; Pentazocine; Rats; Receptors, Opioid, delta; Receptors, Opioid, mu; Reward

2015
Sexual performance and precontact 50-kHz ultrasonic vocalizations in WAG/Rij rats: effects of opioid receptor treatment.
    Epilepsy & behavior : E&B, 2014, Volume: 39

    Topics: Animals; Disease Models, Animal; Epilepsy, Absence; Female; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Opioid; Reward; Sexual Behavior, Animal; Vocalization, Animal

2014
A pharmacogenetic determinant of mu-opioid receptor antagonist effects on alcohol reward and consumption: evidence from humanized mice.
    Biological psychiatry, 2015, May-15, Volume: 77, Issue:10

    Topics: Alcohol Drinking; Animals; Conditioning, Operant; Electric Stimulation; Ethanol; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Naltrexone; Receptors, Opioid, mu; Reward; Self Administration

2015
Complexities of the mu opioid receptor.
    Biological psychiatry, 2015, May-15, Volume: 77, Issue:10

    Topics: Alcohol Drinking; Animals; Humans; Male; Naltrexone; Receptors, Opioid, mu; Reward

2015
Pharmacotherapy: Quest for the quitting pill.
    Nature, 2015, Jun-25, Volume: 522, Issue:7557

    Topics: Animals; Behavior, Addictive; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Clinical Trials as Topic; Cocaine-Related Disorders; Counseling; Dopamine; Drug Discovery; Drug Industry; Humans; Ibogaine; Lobeline; Molecular Targeted Therapy; Naloxone; Naltrexone; Oligopeptides; Opioid-Related Disorders; Pleasure; Rats; Receptors, Nicotinic; Reward; Substance-Related Disorders; Tobacco Use Disorder; Vaccines; Vesicular Monoamine Transport Proteins

2015
Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.
    ACS chemical neuroscience, 2015, Nov-18, Volume: 6, Issue:11

    Topics: Analgesics, Opioid; Animals; Cocaine; Cocaine-Related Disorders; Conditioning, Psychological; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Male; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Morphinans; Naltrexone; Nociception; Nuclear Receptor Subfamily 1, Group F, Member 1; Random Allocation; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Reward; Spatial Behavior

2015
Cannabidiol disrupts the reconsolidation of contextual drug-associated memories in Wistar rats.
    Addiction biology, 2017, Volume: 22, Issue:3

    Topics: Animals; Cannabidiol; Cocaine; Conditioning, Classical; Cues; Disease Models, Animal; Male; Memory; Mental Recall; Morphine; Naltrexone; Rats; Rats, Wistar; Reward

2017
The µ-opioid system promotes visual attention to faces and eyes.
    Social cognitive and affective neuroscience, 2016, Volume: 11, Issue:12

    Topics: Adult; Analgesics, Opioid; Attention; Cues; Eye Movements; Face; Humans; Male; Morphine; Naltrexone; Narcotic Antagonists; Receptors, Opioid, mu; Reward; Social Behavior; Visual Perception; Young Adult

2016
Choice between delayed food and immediate oxycodone in rats.
    Psychopharmacology, 2016, Volume: 233, Issue:23-24

    Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Behavior, Animal; Choice Behavior; Delay Discounting; Disease Models, Animal; Eating; Feeding Behavior; Humans; Male; Naltrexone; Oxycodone; Rats; Reward; Time Factors

2016
Evaluation of effect of minocycline on rewarding potential and alcohol relapse in place preference model in mice.
    Neuroscience letters, 2017, 05-10, Volume: 649

    Topics: Alcohol Drinking; Alcoholism; Animals; Conditioning, Classical; Conditioning, Operant; Disease Models, Animal; Ethanol; Extinction, Psychological; Male; Mice; Minocycline; Naltrexone; Reward; Secondary Prevention

2017
Increased ethanol drinking in "humanized" mice expressing the mu opioid receptor A118G polymorphism are mediated through sex-specific mechanisms.
    Brain research bulletin, 2018, Volume: 138

    Topics: Alcohol Drinking; Alleles; Analgesics, Non-Narcotic; Analysis of Variance; Animals; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Ethanol; Female; Genotype; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutagenesis, Site-Directed; Naltrexone; Narcotic Antagonists; Polymorphism, Single Nucleotide; Quinine; Receptors, Opioid, mu; Reflex; Reward; Self Administration; Self Stimulation; Sex Characteristics

2018
The efficacy of (+)-Naltrexone on alcohol preference and seeking behaviour is dependent on light-cycle.
    Brain, behavior, and immunity, 2018, Volume: 67

    Topics: Animals; Choice Behavior; Circadian Rhythm; Drug-Seeking Behavior; Ethanol; Hypothalamus; Immunity, Innate; Male; Mice, Inbred BALB C; Naltrexone; Nucleus Accumbens; Photoperiod; Reward; Toll-Like Receptor 4

2018
Choice between delayed food and immediate opioids in rats: treatment effects and individual differences.
    Psychopharmacology, 2017, Volume: 234, Issue:22

    Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Choice Behavior; Conditioning, Operant; Delay Discounting; Dose-Response Relationship, Drug; Feeding Behavior; Individuality; Injections, Intravenous; Male; Naltrexone; Oxycodone; Piperidines; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Remifentanil; Reward; Self Administration; Time Factors

2017
Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2018, Volume: 43, Issue:5

    Topics: Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Drug Interactions; Dynorphins; Excitatory Postsynaptic Potentials; Extinction, Psychological; Male; Microinjections; Miniature Postsynaptic Potentials; Naltrexone; Orexins; Paraventricular Hypothalamic Nucleus; Rats; Reward; Self Administration

2018
Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.
    Journal of substance abuse treatment, 2018, Volume: 85

    Topics: Adult; Brain; Delayed-Action Preparations; Facial Recognition; Female; Humans; Magnetic Resonance Imaging; Maternal Behavior; Motivation; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Reward

2018
Bupropion and naltrexone combination alters high fructose corn syrup self-administration and gene expression in rats.
    Neuropharmacology, 2018, Volume: 135

    Topics: Animals; Anti-Obesity Agents; Brain; Bupropion; Drug Combinations; Feeding Behavior; Gene Expression Regulation; High Fructose Corn Syrup; Male; Motor Activity; Naltrexone; Random Allocation; Rats, Sprague-Dawley; Reward; RNA, Messenger; Self Administration

2018
Ethanol Exposure History and Alcoholic Reward Differentially Alter Dopamine Release in the Nucleus Accumbens to a Reward-Predictive Cue.
    Alcoholism, clinical and experimental research, 2018, Volume: 42, Issue:6

    Topics: Animals; Conditioning, Classical; Cues; Dopamine; Electrochemical Techniques; Ethanol; Male; Naltrexone; Nucleus Accumbens; Rats; Reward

2018
Antagonism of μ-opioid receptors reduces sensation seeking-like behavior in mice.
    Behavioural brain research, 2019, 02-01, Volume: 359

    Topics: Animals; Appetitive Behavior; Brain; Conditioning, Operant; Dose-Response Relationship, Drug; Exploratory Behavior; Male; Mice, Inbred C57BL; Morphinans; Motivation; Motor Activity; Naltrexone; Narcotic Antagonists; Random Allocation; Receptors, Opioid; Receptors, Opioid, mu; Reward

2019
Effects of opioid receptor ligands in rats trained to discriminate 22 from 2 hours of food deprivation suggest a lack of opioid involvement in eating for hunger.
    Behavioural brain research, 2020, 02-17, Volume: 380

    Topics: Analgesics, Opioid; Animals; Behavior, Animal; Conditioning, Operant; Discrimination Learning; Feeding Behavior; Food Deprivation; Hunger; Male; Naltrexone; Narcotic Antagonists; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Reward; Satiation; Time Perception

2020
Dopaminergic and opioidergic regulation during anticipation and consumption of social and nonsocial rewards.
    eLife, 2020, 10-13, Volume: 9

    Topics: Adult; Amisulpride; Dopamine Antagonists; Emotions; Female; Food; Humans; Male; Naltrexone; Narcotic Antagonists; Pleasure; Reward; Young Adult

2020
The role of opioidergic system in modulating cost/benefit decision-making in alcohol-preferring AA rats and Wistar rats.
    Behavioural pharmacology, 2021, 04-01, Volume: 32, Issue:2&3

    Topics: Alcohol Drinking; Analgesics, Opioid; Animals; Behavior, Animal; Cost-Benefit Analysis; Decision Making; Gambling; Male; Morphine; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Reward; Sucrose

2021
Examining a brief measure and observed cutoff scores to identify reward and relief drinking profiles: Psychometric properties and pharmacotherapy response.
    Drug and alcohol dependence, 2022, 03-01, Volume: 232

    Topics: Acamprosate; Alcohol Deterrents; Alcohol Drinking; Alcoholism; Female; Humans; Male; Naltrexone; Psychometrics; Reward

2022
Pharmacological investigations of effort-based decision-making in humans: Naltrexone and nicotine.
    PloS one, 2022, Volume: 17, Issue:10

    Topics: Adult; Cholinergic Agents; Decision Making; Dopamine; Humans; Motivation; Naltrexone; Nicotine; Pilot Projects; Reward

2022